• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PROTAC介导的核受体激活而非降解揭示了复杂的配体-受体相互作用网络。

PROTAC-mediated activation, rather than degradation, of a nuclear receptor reveals complex ligand-receptor interaction network.

作者信息

Huber Andrew D, Lin Wenwei, Poudel Shyaron, Miller Darcie J, Chen Taosheng

机构信息

Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, 262 Danny Thomas Place, MS 1000, Memphis, TN 38105-3678, USA.

Department of Structural Biology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA.

出版信息

Structure. 2024 Dec 5;32(12):2352-2363.e8. doi: 10.1016/j.str.2024.09.016. Epub 2024 Oct 9.

DOI:10.1016/j.str.2024.09.016
PMID:39389062
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11647748/
Abstract

Proteolysis-targeting chimeras (PROTACs) are heterobifunctional molecules containing a ligand for a protein of interest linked to an E3 ubiquitin ligase ligand that induce protein degradation through E3 recruitment to the target protein. Small changes in PROTAC linkers can have drastic consequences, including loss of degradation activity, but the structural mechanisms governing such changes are unclear. To study this phenomenon, we screened PROTACs of diverse targeting modalities and identified dTAG-13 as an activator of the xenobiotic-sensing pregnane X receptor (PXR), which promiscuously binds various ligands. Characterization of dTAG-13 analogs and precursors revealed interplay between the PXR-binding moiety, linker, and E3 ligand that altered PXR activity without inducing degradation. A crystal structure of PXR ligand binding domain bound to a precursor ligand showed ligand-induced binding pocket distortions and a linker-punctured tunnel to the protein exterior at a region incompatible with E3 complex formation, highlighting the effects of linker environment on PROTAC activity.

摘要

蛋白酶靶向嵌合体(PROTACs)是异双功能分子,包含与E3泛素连接酶配体相连的目标蛋白配体,通过将E3招募到目标蛋白来诱导蛋白质降解。PROTAC连接子的微小变化可能会产生巨大影响,包括降解活性丧失,但控制此类变化的结构机制尚不清楚。为了研究这一现象,我们筛选了多种靶向模式的PROTACs,并确定dTAG-13是异生素感应孕烷X受体(PXR)的激活剂,PXR可与多种配体随意结合。dTAG-13类似物和前体的表征揭示了PXR结合部分、连接子和E3配体之间的相互作用,这种相互作用改变了PXR活性但未诱导降解。与前体配体结合的PXR配体结合域的晶体结构显示,配体诱导结合口袋变形,并且在与E3复合物形成不相容的区域有一条连接子穿透到蛋白质外部的通道,突出了连接子环境对PROTAC活性的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b340/11647748/772d0c60328a/nihms-2040041-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b340/11647748/e8ee0b9bcc22/nihms-2040041-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b340/11647748/a33681576ae1/nihms-2040041-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b340/11647748/bc8ab31f751a/nihms-2040041-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b340/11647748/b99798917cb5/nihms-2040041-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b340/11647748/e6632716d93a/nihms-2040041-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b340/11647748/772d0c60328a/nihms-2040041-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b340/11647748/e8ee0b9bcc22/nihms-2040041-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b340/11647748/a33681576ae1/nihms-2040041-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b340/11647748/bc8ab31f751a/nihms-2040041-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b340/11647748/b99798917cb5/nihms-2040041-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b340/11647748/e6632716d93a/nihms-2040041-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b340/11647748/772d0c60328a/nihms-2040041-f0007.jpg

相似文献

1
PROTAC-mediated activation, rather than degradation, of a nuclear receptor reveals complex ligand-receptor interaction network.PROTAC介导的核受体激活而非降解揭示了复杂的配体-受体相互作用网络。
Structure. 2024 Dec 5;32(12):2352-2363.e8. doi: 10.1016/j.str.2024.09.016. Epub 2024 Oct 9.
2
Accurate PROTAC-targeted degradation prediction with DegradeMaster.使用DegradeMaster进行准确的PROTAC靶向降解预测。
Bioinformatics. 2025 Jul 1;41(Supplement_1):i342-i351. doi: 10.1093/bioinformatics/btaf191.
3
In-Cell Approach to Evaluate E3 Ligases for Use in Targeted Protein Degradation.用于评估靶向蛋白质降解中E3连接酶的细胞内方法。
J Am Chem Soc. 2025 Jun 25;147(25):21560-21574. doi: 10.1021/jacs.5c02741. Epub 2025 Jun 10.
4
Epigenetic therapy meets targeted protein degradation: HDAC-PROTACs in cancer treatment.表观遗传疗法与靶向蛋白质降解相结合:癌症治疗中的组蛋白去乙酰化酶-蛋白酶体靶向嵌合体
Future Med Chem. 2025 Jul 16:1-13. doi: 10.1080/17568919.2025.2533113.
5
Mechanistic insights into PROTAC-mediated degradation through an integrated framework of molecular dynamics, free energy landscapes, and quantum mechanics: A case study on kinase degraders.通过分子动力学、自由能景观和量子力学的综合框架对PROTAC介导的降解的机理洞察:以激酶降解剂为例
J Comput Aided Mol Des. 2025 Jul 15;39(1):51. doi: 10.1007/s10822-025-00630-3.
6
Methods to accelerate PROTAC drug discovery.加速PROTAC药物发现的方法。
Biochem J. 2025 Jun 25;482(13):BCJ20243018. doi: 10.1042/BCJ20243018.
7
Optimization of the PROTAC linker region of the proteasome substrate receptor hRpn13 rationalized by structural modeling with molecular dynamics.通过分子动力学结构建模对蛋白酶体底物受体hRpn13的PROTAC接头区域进行优化
J Biol Chem. 2025 Apr 19;301(6):108520. doi: 10.1016/j.jbc.2025.108520.
8
Short-Term Memory Impairment短期记忆障碍
9
Commiphora myrrha resin extract-modulated cytochrome P-450 2C9 enzyme expression in cultured Hep G2 cells is associated with resin extract-derived metabolites binding to Pregnane X receptor.没药树脂提取物调节培养的Hep G2细胞中细胞色素P-450 2C9酶的表达与树脂提取物衍生的代谢产物与孕烷X受体结合有关。
BMC Complement Med Ther. 2025 Jul 9;25(1):247. doi: 10.1186/s12906-025-04998-5.
10
Equine lentivirus Gag protein degrades mitochondrial antiviral signaling protein via the E3 ubiquitin ligase Smurf1.马慢病毒Gag蛋白通过E3泛素连接酶Smurf1降解线粒体抗病毒信号蛋白。
J Virol. 2025 Jan 31;99(1):e0169124. doi: 10.1128/jvi.01691-24. Epub 2024 Dec 12.

引用本文的文献

1
Targeting pregnane X receptor with a potent agonist-based PROTAC to delay colon cancer relapse.用基于强效激动剂的PROTAC靶向孕烷X受体以延缓结肠癌复发。
Oncogenesis. 2025 Aug 30;14(1):34. doi: 10.1038/s41389-025-00573-2.
2
Mechanisms and Therapeutic Advances of PXR in Metabolic Diseases and Cancer.孕烷X受体在代谢性疾病和癌症中的作用机制及治疗进展
Int J Mol Sci. 2025 Aug 20;26(16):8029. doi: 10.3390/ijms26168029.
3
First-in-Class Small Molecule Degrader of Pregnane X Receptor Enhances Chemotherapy Efficacy.首个孕烷 X 受体小分子降解剂增强化疗疗效。

本文引用的文献

1
Design and Evaluation of PROTACs Targeting Acyl Protein Thioesterase 1.设计和评价靶向酰基蛋白硫酯酶 1 的 PROTACs。
Chembiochem. 2024 Feb 16;25(4):e202300736. doi: 10.1002/cbic.202300736. Epub 2024 Jan 9.
2
A bromodomain-independent mechanism of gene regulation by the BET inhibitor JQ1: direct activation of nuclear receptor PXR.BET 抑制剂 JQ1 通过一种非溴结构域依赖的机制调控基因表达:直接激活核受体 PXR。
Nucleic Acids Res. 2024 Feb 28;52(4):1661-1676. doi: 10.1093/nar/gkad1175.
3
The F-box-only protein 44 regulates pregnane X receptor protein level by ubiquitination and degradation.
J Med Chem. 2024 Oct 24;67(20):18549-18575. doi: 10.1021/acs.jmedchem.4c01926. Epub 2024 Oct 15.
仅含F-box结构域蛋白44通过泛素化和降解作用调节孕烷X受体蛋白水平。
Acta Pharm Sin B. 2023 Nov;13(11):4523-4534. doi: 10.1016/j.apsb.2023.07.014. Epub 2023 Jul 20.
4
DNA-encoded library-enabled discovery of proximity-inducing small molecules.DNA 编码库助力发现诱导邻近小分子的化合物。
Nat Chem Biol. 2024 Feb;20(2):170-179. doi: 10.1038/s41589-023-01458-4. Epub 2023 Nov 2.
5
Ligand flexibility and binding pocket malleability cooperate to allow selective PXR activation by analogs of a promiscuous nuclear receptor ligand.配体灵活性与结合口袋可塑性协同作用,使一种混杂的核受体配体类似物能够选择性激活孕烷X受体。
Structure. 2023 Dec 7;31(12):1545-1555.e9. doi: 10.1016/j.str.2023.08.020. Epub 2023 Sep 19.
6
Targeted kinase degradation via the KLHDC2 ubiquitin E3 ligase.通过 KLHDC2 泛素 E3 连接酶靶向降解激酶。
Cell Chem Biol. 2023 Nov 16;30(11):1414-1420.e5. doi: 10.1016/j.chembiol.2023.07.008. Epub 2023 Aug 10.
7
Structure-guided approach to modulate small molecule binding to a promiscuous ligand-activated protein.基于结构的方法调节小分子与多功能配体激活蛋白的结合。
Proc Natl Acad Sci U S A. 2023 Mar 7;120(10):e2217804120. doi: 10.1073/pnas.2217804120. Epub 2023 Feb 27.
8
An overview of PROTACs: a promising drug discovery paradigm.蛋白水解靶向嵌合体(PROTACs)概述:一种前景广阔的药物发现模式。
Mol Biomed. 2022 Dec 20;3(1):46. doi: 10.1186/s43556-022-00112-0.
9
Regulation of Nuclear Receptors PXR and CAR by Small Molecules and Signal Crosstalk: Roles in Drug Metabolism and Beyond.小分子和信号串扰对核受体 PXR 和 CAR 的调节:在药物代谢及其他方面的作用。
Drug Metab Dispos. 2023 Feb;51(2):228-236. doi: 10.1124/dmd.122.000858. Epub 2022 Sep 18.
10
SJPYT-195: A Designed Nuclear Receptor Degrader That Functions as a Molecular Glue Degrader of GSPT1.SJPYT - 195:一种设计的核受体降解剂,作为GSPT1的分子胶降解剂发挥作用。
ACS Med Chem Lett. 2022 Jul 15;13(8):1311-1320. doi: 10.1021/acsmedchemlett.2c00223. eCollection 2022 Aug 11.